DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Ausgabe 08 · Volume 59 · August 2021 DOI: 10.1055/s-011-51669


54. Jahrestagung & 31. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH (Hybrid Veranstaltung)
Linz, 09.-11.09.2021

Kongresspräsident: Prim. Univ.-Prof. Dr. Michael Gschwantler Kongresssekretäre: Univ.-Prof. Dr. Alexander R. Moschen PhD Assoz.Prof. Priv.-Doz. Dr. Thomas Reiberger OA Dr. Alexander Ziachehabi Fortbildungskurs: Univ.-Prof. Dr. Peter Ferenci Univ.-Prof. Dr. Heinz Zoller Prim. Univ.-Prof. Dr. Michael Gschwantler
Abstracts (HTML) Abstracts (PDF) Autorenliste
P46
Simbrunner, B; Villesen, I; Scheiner, B; Bauer, DJ; Paternostro, R; Schwabl, P; Stättermayer, A; Marculescu, R; Quehenberger, P; Pinter, M; Trauner, M; Karsdal, M; Reiberger, T; Mandorfer, M; Leeming, D: Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen
P47
Simbrunner, B; Caparrós, E; Bauer, DJ; Scheiner, B; Paternostro, R; Schwabl, P; Stättermayer, A; Pinter, M; Trauner, M; Mandorfer, M; Reiberger, T; Francés, R: The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis
P48
Simbrunner, B; Hartl, L; Jachs, M; Bauer, DJ; Scheiner, B; Paternostro, R; Stättermayer, A; Pinter, M; Trauner, M; Mandorfer, M; Reiberger, T: Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation
P49
Stadlbauer, V; Jud, P; Hackl, G; Reisinger, AC; Eller, P; Horvath, A: Impact of COVID-19 on rare diseases: Report of three cases of acute hepatic porphyria affected by the pandemic
P50
Hartl, L; Jachs, M; Simbrunner, B; Bauer, DJ; Semmler, G; Trauner, M; Mandorfer, M; Reiberger, T: Risk evaluation for acute kidney injury and acute-on-chronic liver failure via a blood-based biomarker panel in patients with cirrhosis
P51
Müllner-Bucsics, TA; Schönhofer, K; Schoder, M; Jonas, JP; Bauer, D; Hartl, L; Jachs, M; Wolf, F; Karner, J; Karnel, F; Grünberger, T; Trauner, M; Mandorfer, M; Reiberger, T: Covered TIPS improves renal function in patients with cirrhosis and ascites
P52
Müllner-Bucsics, TA; Lampichler, K; Vierziger, C; Schoder, M; Wolf, F; Bauer, D; Simbrunner, B; Hartl, L; Jachs, M; Trauner, M; Grünberger, T; Karnel, F; Mandorfer, M; Reiberger, T: Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis
P53
Pomej, K; Scheiner, B; Balcar, L; Nussbaumer, RJ; Weinzierl, J; Paternostro, R; Simbrunner, B; Hartl, L; Jachs, M; Bauer, D; Semmler, G; Stättermayer, A; Pinter, M; Trauner, M; Quehenberger, P; Reiberger, T; Mandorfer, M: Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease
P54
Pinter non-author presenter, M; Finn, R; De Toni, E; Chung Cheung Yau, T; Yen, C; Hsu, C; Chan, S; He, A; Galle, P; Trojan, J; Stirnimann, G; Baron, A; Acosta-Rivera, M; Goyal, L; Wang, C; Abada, P; Widau, R; Zhu, A: Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study
P55
Pomej, K; Balcar, L; Scheiner, B; Semmler, G; Meischl, T; Mandorfer, M; Reiberger, T; Müller, CJ; Trauner, M; Pinter, M: Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib
P56
Grander, C; Riederer, M; Grander, W; Gatterer, L; Marksteiner, J; Tilg, H: Liver and heart fibrosis develops simultaneously in patients with alcohol use disorder - a preliminary report of the HALFWAY study
P57
Balcar, L; Semmler, G; Wernly, S; Bachmayer, S; Egger, M; Semmler, M; Aigner, E; Niederseer, D; Datz, C: PNPLA3 and TM6SF2 are neither associated with decreased cardiovascular nor increased liver-related mortality in the general population
P58
Balcar, L; Pomej, K; Mandorfer, M; Meischl, T; Müller, C; Trauner, M; Reiberger, T; Pinter, M; Scheiner, B: The impact of betablocker treatment on cancer prognosis in patients with advanced hepatocellular carcinoma receiving sorafenib treatment
P59
Balcar, L; Scheiner, B; Paternostro, R; Simbrunner, B; Hartl, L; Jachs, M; Bauer, D; Semmler, G; Stättermayer, AF; Pinter, M; Quehenberger, P; Trauner, M; Reiberger, T; Mandorfer, M: Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease
P60
Balcar, L; Semmler, G; Oberkofler, H; Zandanell, S; Strasser, M; Datz, L; Niederseer, D; Feldman, A; Stickel, F; Datz, C; Paulweber, B; Aigner, E: PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center
P61
Balcar, L; Scheiner, B; Nussbaumer, RJ; Weinzierl, J; Paternostro, R; Simbrunner, B; Hartl, L; Jachs, M; Bauer, D; Stättermayer, AF; Semmler, G; Pinter, M; Quehenberger, P; Trauner, M; Reiberger, T; Lisman, T; Mandorfer, M: Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease
P62
Hartl, L; Simbrunner, B; Jachs, M; Bauer, DJ; Semmler, G; Scheiner, B; Trauner, M; Mandorfer, M; Reiberger, T: Increasing ACE activity in liver disease impacts on fibrinolysis and inflammation - a potential link to COVID-19
P63
Jachs, M; Hartl, L; Simbrunner, B; Bauer, D; Paternostro, R; Scheiner, B; Schwabl, P; Stättermayer, AF; Pinter, M; Eigenbauer, E; Quehenberger, P; Trauner, M; Reiberger, T; Mandorfer, M: NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death
P64
Jachs, M; Binter, T; Schmidbauer, C; Strasser, M; Laferl, H; Hametner-Schreil, S; Lindorfer, A; Dax, K; Stauber, R; Kessler, H; Bernhofer, S; Loacker, L; Bota, S; Santonja, I; Munda, P; Gschwantler, M; Peck-Radosavljevic, M; Holzmann, H; Zoller, H; Ferenci, P; Reiberger, T: Update on the Austrian epidemiology of Hepatitis D Virus (HDV)
P65
Wernly, S; Semmler, G; Wernly, B; Datz, C: NAFLD is not independently associated with H. pylori in an Austrian screening collective
P66
Pramhofer, P; Dorn, L; Mayer, A; Maieron, A: Secondary Sclerosing Cholangitis of the Critically Ill Patient suffering from COVID19
P67
Razpotnik, M; Bota, S; Wimmer, P; Urak, C; Hackl, M; Alber, H; Peck-Radosavljevic, M: The association of liver steatosis assessed by the controlled attenuated parameter and severity of liver disease with the presence of cirrhotic cardiomyopathy
P68
Urak, C; Bota, S; Razpotnik, M; Hucke, F; Peck-Radosavljevic, M: Value of Hitachi Shear Wave Elastography (SWE) to rule-in and rule-out the presence of esophageal varices in patients with compensated advanced liver disease
P69
Grabherr, F; Grander, C; Enrich, B; Meyer, M; Mayr, L; Schwärzler, J; Pedrini, A; Effenberger, M; Adolph, T; Tilg, H: Association of hepatic Meteorin-like and Krüppel-like factor 3 with weight loss after laporoscopic adjustable gastric banding
P70
Hucke, F; Pinter, M; Bolf, D; Bota, S; Peck-Radosavljevic, M: Epidemiological trends of Hepatobiliary Carcinomas in Austria 2009-2018 - an update
P71
Hucke, F; Knaus, A; Fürstner, M; Bota, S; Hausegger, K; Peck-Radosavljevic, M: Combination of TACE plus RFA in early and intermediate stage HCC patients
P72
Aliwa, BO; Horvath, A; Traub, J; Feldbacher, N; Stadlbauer-Köllner, V: Gut Microbiome Dysbiosis, Bile acids, and Sarcopenia in Liver Cirrhosis
P73
Dax, K; Reiter, S; Stampfel, G; Penner, A; Zollner, A; Watschinger, C; Moschen, A: COVID19 vaccination in liver transplant recipients
P74
Gatterer, L; Grander, C; Riederer, M; Grander, W; Marksteiner, J; Tilg, H: Diet in alcohol withdrawal - coffee consumption is associated with reduced risk of alcohol-induced liver fibrosis and steatosis
P75
Pertler, E; Panzer, M; Viveiros, A; Schäfer, B; Plaikner, M; Henninger, B; Baumgartner, N; Tilg, H; Zoller, H: The Phenotypic Spectrum of Patients with Genetic variants in Ceruloplasmin
P76
Reiter, V; Schöfl, R; Hametner-Schreil, S: Lebertransplantation bei HCC - ein Follow-up am Ordensklinikum Linz in Hinblick auf Transplantationskriterien und Outcome
P77
Semmler, G; Pomej, K; Bauer, DJ; Balcar, L; Simbrunner, B; Binter, T; Hartl, L; Becker, J; Pinter, M; Quehenberger, P; Trauner, M; Mandorfer, M; Lisman, T; Reiberger, T; Scheiner, B: Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease
P78
Schmidbauer, C; Schwarz, M; Chromy, D; Bangert, C; Jachs, M; Reibergern, T; Gschwantler, M: Immediate-type hypersensitivity reaction to bulevirtide in a female patient with HBV/HDV-associated compensated cirrhosis
P79
Reiter, S; Dax, K; Penner, A; Watschinger, C; Zollner, A; Moschen, AR: COVID-19 vaccination in patients with autoimmune hepatitis
P80
Gensluckner, S; Flasch-Polly, C; Aigner, E: Repeated episodes of severe metamizole-induced hepatotoxicity
P81
Loschko, N; Dax, K; Reiter, S; Moschen, AR: Listeria-associated multiple granulomatous liver abscesses complicated by vena cava inferior thrombosis
P82
Stauber, R; Rainer, F; Jager, M; Horhat, A; Rautou, P; Stefanescu, H; Lackner, C: Histological lesions can predict response to corticosteroids in patients with severe alcohol-related steatohepatitis
P83
Schwarz, M; Schmidbauer, C; Hübl, W; Mandorfer, M; Gschwantler, M; Reiberger, T: VICI-REG - Vienna Cirrhosis registry: A retrospective, epidemiological analysis of cirrhostic patients at a tertiary care center in Vienna, Austria. Preliminary results
P84
Stehrer, R; Rugani, P; Stadlbauer-Köllner, V: Zahnärztliche Herdsanierung vor Lebertransplantation - eine retrospektive Studie
P85
Gesierich, FJ; Hucke, F; Bota, S; Peck-Radosavljevic, M: Bacterial spectrum and antibiotic resistance in patients with spontaneous bacterial peritonitis in southern Austria
P86
Semmler, G; Balcar, L; Lindorfer, A; Bartl, S; Hametner-Schreil, S; Gensluckner, S; Pomej, K; Bauer, DJ; Simbrunner, B; Trauner, M; Hofer, H; Schöfl, R; Aigner, E; Datz, C; Mandorfer, M; Reiberger, T; Scheiner, B: Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study
P87
Hofer, BS; Simbrunner, B; Bauer, D; Paternostro, R; Schwabl, P; Scheiner, B; Hartl, L; Jachs, M; Stättermayer, A; Trauner, M; Mandorfer, M; Reiberger, T: Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis
P88
Balazs, I; Horvath, A; Leber, B; Feldbacher, N; Fauler, G; Stadlbauer, V: Gut microbiome composition in liver cirrhosis is associated with serum bile acid profile
P89
Hofer, BS; Paternostro, R; Simbrunner, B; Semmler, G; Schwabl, P; Scheiner, B; Bucsics, T; Bauer, D; Trauner, M; Mandorfer, M; Reiberger, T: The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices